Table 2.

Overall and cancer specific survival after stereotactic ablative radiotherapy (SABR) and thoracoscopic resection of lung cancer

	Hazard ratio (95% CI), P value
	Full cohort	Matched cohort
SABR v thoracoscopic SLR, tumor size ≤2 cm
Overall survival	2.11 (1.67 to 2.68), <0.001	1.80 (1.33 to 2.43), <0.001
Cancer specific survival	1.47 (0.95 to 2.28), 0.08	1.32 (0.77 to 2.26), 0.32
SABR v thoracoscopic resection tumor size ≤5 cm
All cause survival	2.81 (2.48 to 3.17), <0.001	1.92 (1.62 to 2.26), <0.001
Cancer specific survival	2.31 (1.84 to 2.90), <0.001	2.10 (1.52 to 2.89), <0.001

SLR=thoracic sublobar lung resection.